Darier Disease

Hansen’s disease (leprosy) is endemic in more than 100 countries worldwide, with over 200,000 new diagnoses each year and more than 4 million people living with some form of HD-related impairment. The World Health Organization’s ‘Global Leprosy Strategy’ timeline for Hansen’s disease elimination indicates that it will be encountered in clinical practice in endemic countries for at least another decade. Increasing north-to-south migration, global travel and overseas medical work mean that physicians in non-endemic countries will also encounter patients with Hansen’s disease, which can affect people for many years before diagnosis and after treatment. For busy clinicians, it represents a challenge, in terms of disease learning and updating knowledge and skills.

This book discusses Chagas disease and its etiological agent, including information on relevant clinical aspects such as diagnosis, treatment, biomarkers, and so on. It also presents information about cellular, molecular, and biochemical characteristics of the parasite-host interactions.

Breed Predispositions to Dental and Oral Disease in Dogs  is an accessible guide to hereditary oral and dental disease. The text is designed to help veterinarians make informed clinical decisions and better communicate with clients. Comprehensive in scope, the book provides a thorough understanding of the differences between large and small dogs as related to effective dental treatment.

Since the publication of the first edition of Infectious Disease Management in Animal Shelters in 2009, research and practice in the field of shelter medicine have advanced significantly. This updated second edition of that seminal work provides the most up-to-date and comprehensive guide to preventing, managing, and treating infectious diseases affecting cats, dogs and exotic small companion mammals in animal shelters.

This book details the benefits of palliative care to improve the lives of patients with serious lung disease and their caregivers. Palliative care is specialized medical care for people living with a serious illness. This type of care is focused on providing relief from the symptoms and stress of a serious illness, and is often described as “an extra layer of support” for patients and their caregivers, as patients with malignant and nonmalignant lung disease experience great symptom burden and have advanced care planning needs.

The novel viral pandemic coronavirus disease 2019 (COVID-19) has sparked uncertainties and controversies as to its origin, epidemiology, and natural course. In this situation, the medical disciplines have strived to contribute to a better understanding of the disease with the best available evidence gained from the scientific method of observation and statistics. The study of the cutaneous manifestations of COVID-19 has evolved with the hope that they may be useful as markers for the disease, for prognostication, and further insights into the pathogenesis of the disease manifestations. In the wake of COVID-19, we have decided to take a more general look at the hair and scalp in infectious disease. Specifically, we must recognize that infectious diseases have wider preconditions besides the infectious agents, to include environmental and societal factors. Unless we also take account of the ecological, immunological, and behavioral circumstances that affect the emergence and spread of infectious diseases, including those of the hair and scalp, our knowledge of the pathogens and their connection to clinical disease presentation remain only partial and incomplete.